Milo Trusheim
米洛·特鲁谢姆
MBA, PhD
Research Affiliate, MIT NEWDIGSMIT NEWDIGS研究员
👥Biography 个人简介
Expert in AI-driven drug development and precision medicine strategy. Research focuses on how machine learning and data science can accelerate oncology drug development, improve precision medicine trial design, and optimize patient stratification through predictive biomarker identification.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
AI in Oncology Drug Development
Developed frameworks for integrating AI and machine learning into oncology drug development pipelines, including patient stratification, biomarker discovery, and adaptive trial design, improving the success rates of precision oncology programs.
Representative Works 代表性著作
Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers
Nature Reviews Drug Discovery (2007)
Landmark analysis of the strategic and economic framework for biomarker-driven stratified medicine in oncology drug development.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 米洛·特鲁谢姆 的研究动态
Follow Milo Trusheim's research updates
留下邮箱，当我们发布与 Milo Trusheim（Massachusetts Institute of Technology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment